[FATE] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 9.49%
YoY- -87.66%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 14,225 13,412 11,142 15,896 7,558 5,465 2,515 217.11%
PBT -43,308 -55,133 -45,089 -53,112 -58,684 -28,072 -33,520 18.60%
Tax -11,315 8,354 -1,121 -861 0 635 0 -
NP -43,308 -55,133 -45,089 -53,112 -58,684 -28,072 -33,520 18.60%
Tax Rate - - - - - - - -
Total Cost 57,533 68,545 56,231 69,008 66,242 33,537 36,035 36.56%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -304.45 -411.07 -404.68 -334.12 -776.45 -513.67 -1,332.80 -62.59%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.45 -0.58 -0.48 -0.61 -0.68 -0.35 -0.44 1.50%
EPS Diluted -0.45 -0.58 -0.48 -0.61 -0.68 -0.35 -0.44 1.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.